Proven, Trusted Investors in Healthcare Innovation

With over two decades of experience as early stage VC company builders, Hatteras Venture Partners has constructed a risk-mitigated, replicable value creation model. The cutting-edge companies we focus on range from those delivering therapeutic or diagnostic benefits to patients to companies disrupting the status quo in healthcare and accelerating the pace of innovation.


Our Continuum of Investments

Investment Type Example:

Rodin is developing a differentiated approach to Alzheimer’s through targeted epigenetic regulation of synaptic function and health by HDAC complex modulation.

Investment Type Example:

Based on research from UNC-Chapel Hill, Ribometrix is building a technology platform that enables RNA to be targeted with small molecules.

Investment Type Example:

NurseGrid employs a bottom-up, mobile-first solution through a free app for seamless scheduling and shift management for nurses and health techs.

Transformative Therapies

A drug which hits a pathway.

FDA Regulation:

High

Investment Type Example:

Rodin is developing a differentiated approach to Alzheimer’s through targeted epigenetic regulation of synaptic function and health by HDAC complex modulation.

A transformational platform that generates therapies

FDA Regulation:

Medium

Investment Type Example:

Based on research from UNC-Chapel Hill, Ribometrix is building a technology platform that enables RNA to be targeted with small molecules.

A platform driving efficiency in healthcare.

FDA Regulation:

None

Investment Type Example:

NurseGrid employs a bottom-up, mobile-first solution through a free app for seamless scheduling and shift management for nurses and health techs.

Disruptive Technologies

A drug which hits a pathway.

FDA Regulation:

High

A transformational platform that generates therapies.

FDA Regulation:

Medium

A platform driving efficiency in healthcare.

FDA Regulation:

None

Creating Value in Proven Sectors

Our portfolio represents the following proven yet burgeoning sectors.

Investing Nationally

While Hatteras Venture Partners is a recognized leader in the Southeast, our investments reflect markets with attractive dynamics nationwide.

California

GreyBug Inc.

Qpex

SpineAlign

Trefoil Therapeuitics, Inc.

Wildflower Health Inc.

Colorado

Dropworks

Connecticut

Artizan Biosciences, Inc.

Florida

BlinkBio (fka Coferon Inc.)

Georgia

Clearside Biomedical

Massachusetts

Boston Immune Technologies

Curoverse Inc.

Genturi, Inc.

Kymera

Lysosomal Therapeutics Inc.

ORIG3N Inc.

Rodin Therapeutics, Inc.

Sideris Pharmaceuticals Inc.

Michigan

HistoSonics

North Carolina

ArtusLabs

Bivarus, Inc.

CancerGuide Diagnostics

Clinipace

Clinverse Inc.

Contego Medical LLC

Entegrion (Cooper Secondary)

G1 Therapeutics Inc.

GeneCentric

Innocrin Pharmaceuticals

KinoDyn Inc.

Medfusion, Inc.

NeuroTronik Inc.

Respirics (Cooper Secondary)

Ribometrix, Inc.

Spyryx Biosciences Inc.

StrideBio, Inc.

Viamet Pharmaceuticals

New York

Medikidz Inc. / dba Jumo Health

Ohio

Standard Bariatrics, Inc.

Oregon

NurseGrid

Pennsylvania

Embrella Cardiovascular

PhaseBio Pharmaceuticals

TetraLogic

Tennessee

Device Innovation Group

NuSirt Biopharma Inc.

Pathfinder

Texas

Elligo Health Research, Inc.

Ontario

Qvella Corporation